Comparison of effectiveness and safety between conbercept and ranibizumab for treatment of neovascular age-related macular degeneration. A retrospective case-controlled non-inferiority multiple center study

PURPOSE: To compare the efficacy and safety of conbercept and ranibizumab when administered according to a treat-and-extend (TREX) protocol for the treatment of neovascular age-related macular degeneration (AMD) in China. PATIENTS AND METHODS: Between May 2014 and May 2015, 180 patients were treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, J, Sun, D, Lu, H, Dai, R, Xing, L, Dong, H, Wang, L, Wei, D, Jiang, B, Jiao, Y, Jablonski, M M, Charles, S, Gu, W, Chen, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805597/
https://www.ncbi.nlm.nih.gov/pubmed/28937147
http://dx.doi.org/10.1038/eye.2017.187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805597/
https://www.ncbi.nlm.nih.gov/pubmed/28937147
http://dx.doi.org/10.1038/eye.2017.187

Ejemplares similares